In the fifth episode of a six-part interview series on immunotherapy, Marc Voigt, CEO and Executive Director of Immutep (ASX:IMM), explains the complex and heavily regulated process of bringing a new ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Bayer BAYRY announced that the FDA has granted full approval to oncology drug, Vitrakvi (larotrectinib), a first-in-class TRK ...

A "first of its kind" surgery developed in Minnesota to provide relief from debilitating back pain is one step closer to FDA approval ... He found a clinical trial for Synerfuse, the world's ...

[ii] With the FDA recently highlighting the limitations of single-arm trials, utilising the RCT approach can ... providing valuable context and supporting the decision-making process for expedited ...

This composite image made from five file photos shows, from left to right, Liberal Leader Mark Carney on March 21, 2025; Conservative Leader Pierre Poilievre on March 4, 2025; NDP Leader Jagmeet Singh ...

Laravel Process Approval is a Laravel package that makes it easy to add approvals to your Laravel application. It allows you to define approval workflows for any model, and it provides a simple and ...

A Wuhan-based biopharmaceutical company developed technology to synthesize human serum albumin (HSA) from rice, offering a ...

Global Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales and Clinical Trials Insight 2030 ... Opportunity US$ 50 Billion By 2030 Approved Antibodies Dosage, Patent, Pricing ...

As we demonstrated throughout the process to date, we are proud to be community partners in Kuna and will be providing more than $40 million of direct contributions to the community to fund ...

The approval is the third in the US for of Novartis’ kidney disease portfolio. Credit: Taljat David/Shutterstock. The US Food and Drug Administration (FDA) has granted accelerated approval to Novartis ...

SHANGHAI, April 2, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ADC (R&D code: 7MW3711) has been ...